AcoArt Ⅰ / SFA China

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT01850056

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01850056
Other papers using this trial's data
  • Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study Vascular, 2021-06 DOI, PubMed 32903168

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01850056. Randomized; single masking; primary purpose treatment. Start 2013-04 (actual); primary completion 2016-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
AcoArt Ⅰ / SFA China
Condition
Peripheral Artery Disease
Intervention (Device)
drug eluting balloon catheter (trade name: Orchid)
Intervention (Device)
common percutaneous transluminal angioplasty balloon catheter (trade name: Admiral)
Lead sponsor
Acotec Scientific Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct01850056
Content hash
d52c257b23ca9f5c2b4c0e3f8ef306a4e192eff66b714f337d28edfe1bff6701